The global market for Medicinal Exosomes was valued at US$ 261 million in the year 2023 and is projected to reach a revised size of US$ 1295 million by 2030, growing at a CAGR of 18.2% during the forecast period.
Medicinal exosomes are tiny vesicles with a single-layer membrane structure that are actively secreted by cells. The aqueous core is surrounded by a lipid bilayer, and a variety of biological components such as proteins, lipids, and nucleic acids (including mRNA, miRNA, etc.) are encapsulated in its cavity or lipid bilayer. As a drug delivery carrier, medicinal exosomes can deliver drug molecules to target cells in an efficient and specific manner, providing a new idea and practical technology for targeted treatment of diseases. In the field of biotechnology, medicinal exosomes have broad application prospects. For example, exosomes can be targeted to specific cells or tissues in a cell- or tissue-specific manner for drug delivery and treatment.
North American market for Medicinal Exosomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Medicinal Exosomes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Medicinal Exosomes include ExoCoBio, ASFREYA, AM BioTech Co., Ltd., Anjarium Biosciences AG, Creative Biolabs, EXO Biologics SA, Cytiva, STEMON, Exolitus, RoosterBio, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medicinal Exosomes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medicinal Exosomes.
The Medicinal Exosomes market size, estimations, and forecasts are provided in terms of output/shipments (Kilotons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medicinal Exosomes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medicinal Exosomes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ExoCoBio
ASFREYA
AM BioTech Co., Ltd.
Anjarium Biosciences AG
Creative Biolabs
EXO Biologics SA
Cytiva
STEMON
Exolitus
RoosterBio, Inc.
Bioscience Institute
Capricor Therapeutics
ECHO Alotech
EVMed Pro
Anextcell
Shenzhen Beike Biotechnology Co., Ltd.
by Type
Plant-derived Exosomes
Human-derived Exosomes
by Application
Arthritis
Bone Fractures
Premature Ovarian Failure
Macular Degeneration
Heart Failure
Stroke
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medicinal Exosomes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Medicinal Exosomes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Medicinal Exosomes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Medicinal Exosomes Market Overview
1.1 Product Definition
1.2 Medicinal Exosomes by Type
1.2.1 Global Medicinal Exosomes Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Plant-derived Exosomes
1.2.3 Human-derived Exosomes
1.3 Medicinal Exosomes by Application
1.3.1 Global Medicinal Exosomes Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Arthritis
1.3.3 Bone Fractures
1.3.4 Premature Ovarian Failure
1.3.5 Macular Degeneration
1.3.6 Heart Failure
1.3.7 Stroke
1.3.8 Others
1.4 Global Market Growth Prospects
1.4.1 Global Medicinal Exosomes Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Medicinal Exosomes Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Medicinal Exosomes Production Estimates and Forecasts (2019-2030)
1.4.4 Global Medicinal Exosomes Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Medicinal Exosomes Production Market Share by Manufacturers (2019-2024)
2.2 Global Medicinal Exosomes Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Medicinal Exosomes, Industry Ranking, 2022 VS 2023
2.4 Global Medicinal Exosomes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Medicinal Exosomes Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Medicinal Exosomes, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Medicinal Exosomes, Product Offered and Application
2.8 Global Key Manufacturers of Medicinal Exosomes, Date of Enter into This Industry
2.9 Medicinal Exosomes Market Competitive Situation and Trends
2.9.1 Medicinal Exosomes Market Concentration Rate
2.9.2 Global 5 and 10 Largest Medicinal Exosomes Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Medicinal Exosomes Production by Region
3.1 Global Medicinal Exosomes Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Medicinal Exosomes Production Value by Region (2019-2030)
3.2.1 Global Medicinal Exosomes Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Medicinal Exosomes by Region (2025-2030)
3.3 Global Medicinal Exosomes Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Medicinal Exosomes Production by Region (2019-2030)
3.4.1 Global Medicinal Exosomes Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Medicinal Exosomes by Region (2025-2030)
3.5 Global Medicinal Exosomes Market Price Analysis by Region (2019-2024)
3.6 Global Medicinal Exosomes Production and Value, Year-over-Year Growth
3.6.1 North America Medicinal Exosomes Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Medicinal Exosomes Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Medicinal Exosomes Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Medicinal Exosomes Production Value Estimates and Forecasts (2019-2030)
4 Medicinal Exosomes Consumption by Region
4.1 Global Medicinal Exosomes Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Medicinal Exosomes Consumption by Region (2019-2030)
4.2.1 Global Medicinal Exosomes Consumption by Region (2019-2030)
4.2.2 Global Medicinal Exosomes Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Medicinal Exosomes Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Medicinal Exosomes Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Medicinal Exosomes Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Medicinal Exosomes Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Medicinal Exosomes Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Medicinal Exosomes Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Medicinal Exosomes Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Medicinal Exosomes Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Medicinal Exosomes Production by Type (2019-2030)
5.1.1 Global Medicinal Exosomes Production by Type (2019-2024)
5.1.2 Global Medicinal Exosomes Production by Type (2025-2030)
5.1.3 Global Medicinal Exosomes Production Market Share by Type (2019-2030)
5.2 Global Medicinal Exosomes Production Value by Type (2019-2030)
5.2.1 Global Medicinal Exosomes Production Value by Type (2019-2024)
5.2.2 Global Medicinal Exosomes Production Value by Type (2025-2030)
5.2.3 Global Medicinal Exosomes Production Value Market Share by Type (2019-2030)
5.3 Global Medicinal Exosomes Price by Type (2019-2030)
6 Segment by Application
6.1 Global Medicinal Exosomes Production by Application (2019-2030)
6.1.1 Global Medicinal Exosomes Production by Application (2019-2024)
6.1.2 Global Medicinal Exosomes Production by Application (2025-2030)
6.1.3 Global Medicinal Exosomes Production Market Share by Application (2019-2030)
6.2 Global Medicinal Exosomes Production Value by Application (2019-2030)
6.2.1 Global Medicinal Exosomes Production Value by Application (2019-2024)
6.2.2 Global Medicinal Exosomes Production Value by Application (2025-2030)
6.2.3 Global Medicinal Exosomes Production Value Market Share by Application (2019-2030)
6.3 Global Medicinal Exosomes Price by Application (2019-2030)
7 Key Companies Profiled
7.1 ExoCoBio
7.1.1 ExoCoBio Medicinal Exosomes Company Information
7.1.2 ExoCoBio Medicinal Exosomes Product Portfolio
7.1.3 ExoCoBio Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.1.4 ExoCoBio Main Business and Markets Served
7.1.5 ExoCoBio Recent Developments/Updates
7.2 ASFREYA
7.2.1 ASFREYA Medicinal Exosomes Company Information
7.2.2 ASFREYA Medicinal Exosomes Product Portfolio
7.2.3 ASFREYA Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.2.4 ASFREYA Main Business and Markets Served
7.2.5 ASFREYA Recent Developments/Updates
7.3 AM BioTech Co., Ltd.
7.3.1 AM BioTech Co., Ltd. Medicinal Exosomes Company Information
7.3.2 AM BioTech Co., Ltd. Medicinal Exosomes Product Portfolio
7.3.3 AM BioTech Co., Ltd. Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.3.4 AM BioTech Co., Ltd. Main Business and Markets Served
7.3.5 AM BioTech Co., Ltd. Recent Developments/Updates
7.4 Anjarium Biosciences AG
7.4.1 Anjarium Biosciences AG Medicinal Exosomes Company Information
7.4.2 Anjarium Biosciences AG Medicinal Exosomes Product Portfolio
7.4.3 Anjarium Biosciences AG Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Anjarium Biosciences AG Main Business and Markets Served
7.4.5 Anjarium Biosciences AG Recent Developments/Updates
7.5 Creative Biolabs
7.5.1 Creative Biolabs Medicinal Exosomes Company Information
7.5.2 Creative Biolabs Medicinal Exosomes Product Portfolio
7.5.3 Creative Biolabs Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Creative Biolabs Main Business and Markets Served
7.5.5 Creative Biolabs Recent Developments/Updates
7.6 EXO Biologics SA
7.6.1 EXO Biologics SA Medicinal Exosomes Company Information
7.6.2 EXO Biologics SA Medicinal Exosomes Product Portfolio
7.6.3 EXO Biologics SA Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.6.4 EXO Biologics SA Main Business and Markets Served
7.6.5 EXO Biologics SA Recent Developments/Updates
7.7 Cytiva
7.7.1 Cytiva Medicinal Exosomes Company Information
7.7.2 Cytiva Medicinal Exosomes Product Portfolio
7.7.3 Cytiva Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Cytiva Main Business and Markets Served
7.7.5 Cytiva Recent Developments/Updates
7.8 STEMON
7.8.1 STEMON Medicinal Exosomes Company Information
7.8.2 STEMON Medicinal Exosomes Product Portfolio
7.8.3 STEMON Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.8.4 STEMON Main Business and Markets Served
7.8.5 STEMON Recent Developments/Updates
7.9 Exolitus
7.9.1 Exolitus Medicinal Exosomes Company Information
7.9.2 Exolitus Medicinal Exosomes Product Portfolio
7.9.3 Exolitus Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Exolitus Main Business and Markets Served
7.9.5 Exolitus Recent Developments/Updates
7.10 RoosterBio, Inc.
7.10.1 RoosterBio, Inc. Medicinal Exosomes Company Information
7.10.2 RoosterBio, Inc. Medicinal Exosomes Product Portfolio
7.10.3 RoosterBio, Inc. Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.10.4 RoosterBio, Inc. Main Business and Markets Served
7.10.5 RoosterBio, Inc. Recent Developments/Updates
7.11 Bioscience Institute
7.11.1 Bioscience Institute Medicinal Exosomes Company Information
7.11.2 Bioscience Institute Medicinal Exosomes Product Portfolio
7.11.3 Bioscience Institute Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Bioscience Institute Main Business and Markets Served
7.11.5 Bioscience Institute Recent Developments/Updates
7.12 Capricor Therapeutics
7.12.1 Capricor Therapeutics Medicinal Exosomes Company Information
7.12.2 Capricor Therapeutics Medicinal Exosomes Product Portfolio
7.12.3 Capricor Therapeutics Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Capricor Therapeutics Main Business and Markets Served
7.12.5 Capricor Therapeutics Recent Developments/Updates
7.13 ECHO Alotech
7.13.1 ECHO Alotech Medicinal Exosomes Company Information
7.13.2 ECHO Alotech Medicinal Exosomes Product Portfolio
7.13.3 ECHO Alotech Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.13.4 ECHO Alotech Main Business and Markets Served
7.13.5 ECHO Alotech Recent Developments/Updates
7.14 EVMed Pro
7.14.1 EVMed Pro Medicinal Exosomes Company Information
7.14.2 EVMed Pro Medicinal Exosomes Product Portfolio
7.14.3 EVMed Pro Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.14.4 EVMed Pro Main Business and Markets Served
7.14.5 EVMed Pro Recent Developments/Updates
7.15 Anextcell
7.15.1 Anextcell Medicinal Exosomes Company Information
7.15.2 Anextcell Medicinal Exosomes Product Portfolio
7.15.3 Anextcell Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Anextcell Main Business and Markets Served
7.15.5 Anextcell Recent Developments/Updates
7.16 Shenzhen Beike Biotechnology Co., Ltd.
7.16.1 Shenzhen Beike Biotechnology Co., Ltd. Medicinal Exosomes Company Information
7.16.2 Shenzhen Beike Biotechnology Co., Ltd. Medicinal Exosomes Product Portfolio
7.16.3 Shenzhen Beike Biotechnology Co., Ltd. Medicinal Exosomes Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Shenzhen Beike Biotechnology Co., Ltd. Main Business and Markets Served
7.16.5 Shenzhen Beike Biotechnology Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Medicinal Exosomes Industry Chain Analysis
8.2 Medicinal Exosomes Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Medicinal Exosomes Production Mode & Process
8.4 Medicinal Exosomes Sales and Marketing
8.4.1 Medicinal Exosomes Sales Channels
8.4.2 Medicinal Exosomes Distributors
8.5 Medicinal Exosomes Customers
9 Medicinal Exosomes Market Dynamics
9.1 Medicinal Exosomes Industry Trends
9.2 Medicinal Exosomes Market Drivers
9.3 Medicinal Exosomes Market Challenges
9.4 Medicinal Exosomes Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
ExoCoBio
ASFREYA
AM BioTech Co., Ltd.
Anjarium Biosciences AG
Creative Biolabs
EXO Biologics SA
Cytiva
STEMON
Exolitus
RoosterBio, Inc.
Bioscience Institute
Capricor Therapeutics
ECHO Alotech
EVMed Pro
Anextcell
Shenzhen Beike Biotechnology Co., Ltd.
听
听
*If Applicable.
